Literature DB >> 3657794

A synthetic peptide coded for by the pre-S2 region of hepatitis B virus for adding immunogenicity to small spherical particles made of the product of the S gene.

A Machida1, H Ohnuma, E Takai, T Tanaka, Y Itoh, F Tsuda, Y Akahane, S Usuda, T Nakamura, Y Miyakawa.   

Abstract

Small spherical particles produced in the non-permissive phase of hepatitis B virus infection, when the viral genome is integrated into the chromosome of hosts, are rich in the product of the S gene, but poor in the product of the pre-S2 region. For the purpose of adding immunogenicity to spherical particles deficient in the pre-S2 region product, they were conjugated with a synthetic peptide of 19 amino acid residues. The peptide reproduced a hydrophilic area of the pre-S2 region product encoded by viral genomes of subtypes adr, ayw and ayr. The spherical particles supplemented with the pre-S2 peptide raised antibody to the pre-S2 region product in mice, in addition to antibody to the product of the S gene. Antibody to pre-S2 region product, prepared from sera of immunized mice by absorption with the S gene product, bound to spherical particles bearing pre-S2 region product, irrespective of adr, adw, ayw or ayr subtype, and agglutinated hepatitis B virions in immune electron microscopy. Based on the results obtained, the synthetic peptide may prove useful in adding protective efficacy to small spherical particles poor in pre-S2 region product.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3657794     DOI: 10.1016/0161-5890(87)90027-7

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  5 in total

1.  Three envelope proteins of hepatitis B virus: large S, middle S, and major S proteins needed for the formation of Dane particles.

Authors:  K Ueda; T Tsurimoto; K Matsubara
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  Production of hepatitis B virus surface antigen containing pre-S1 and pre-S2 domains by Chinese hamster ovary cells.

Authors:  T Lee; J Inokoshi; M Namiki; H Takeshima; S Omura
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

3.  Stable expression of hepatitis B virus genome in a primate kidney cell.

Authors:  H Takeshima; M Namiki; J Inokoshi; T Lee; A Abe; Y Suzuki; S Omura
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

4.  Enhancement of immunoglobulin G responses in mice against hepatitis B virus surface antigen, influenza virus hemagglutinin vaccine, and tetanus toxoid by 6-O-acylated muramyl dipeptides.

Authors:  T Furuya; Y Kumazawa; H Takimoto; T Nagumo; M Watanabe; C Aizawa; M Kiso; A Hasegawa; K Nomoto
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

5.  Evaluation of the pre-S (pre-S(1)Ag/pre-S(2)Ab) system in hepatitis B virus infection.

Authors:  M I Galán; J Tomás; M C Bernal; F J Salmerón; M C Maroto
Journal:  J Clin Pathol       Date:  1991-01       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.